Core Viewpoint - Nephros, Inc. is set to announce its third-quarter financial results on November 7, 2024, and will host a conference call to discuss these results [1]. Group 1: Financial Results Announcement - Nephros will file its third-quarter financial results after market close on November 7, 2024 [1]. - A conference call will take place on the same day at 4:30 PM ET for discussing the financial results [1]. - Participants can join the call using specific domestic and international access numbers [1]. Group 2: Audio Archive and Replay - An audio archive of the conference call will be available shortly after the call on the Nephros Investor Relations page [2]. - A replay of the call can be accessed until November 14, 2024, using designated numbers and a replay access code [2]. Group 3: Company Overview - Nephros is a leading provider of filtration products for medical, commercial, and industrial markets [3]. - The company utilizes advanced hollow-fiber technology and effective commercial filter media to ensure high water quality by protecting against waterborne contaminants [3].

Core Viewpoint - Nephros, Inc. has effectively responded to recent hurricanes in the southeastern United States by providing essential water filtration solutions to healthcare and nursing facilities, ensuring safe water access during recovery efforts [1][3]. Group 1: Company Response and Capabilities - Nephros has leveraged its disaster response capabilities to deliver crucial water filtration products to affected healthcare facilities, emphasizing the importance of clean water in patient care [2][3]. - The company has shipped a significant number of filters rapidly, responding after hours and ensuring next-day delivery to federal and local disaster response partners [3]. - Nephros' filtration solutions have been deployed across multiple states, including Florida and North Carolina, where they provided immediate protection against water contamination [3]. Group 2: Product Importance and Commitment - The company's filtration products are vital for ensuring purified water for various critical applications, including drinking, dialysis, surgical operations, and general facility hygiene [3]. - Nephros is committed to providing high-quality water filtration solutions in both routine and crisis situations, highlighting the speed and efficiency of its team in maintaining service continuity [3][4]. - The advanced hollow-fiber technology and effective commercial filter media used in Nephros products help protect against waterborne contaminants, ensuring high water quality [4].

Financial Data and Key Metrics Changes - In Q2 2024, net revenue was $3.25 million, down 8% compared to Q2 2023, primarily due to low contributions from emergency response revenue [9][10] - Gross margin remained strong at 59%, flat year-over-year, but decreased from 62% in Q1 2024 due to increased shipping expenses and reserves for slow-moving products [10] - Net loss improved by 33% to $289,000 in Q2 2024 from a loss of $433,000 in Q2 2023, attributed to reduced SG&A expenses [10][11] - For the first half of 2024, net loss decreased 38% to $458,000 from $739,000 in the prior year [11] Business Line Data and Key Metrics Changes - Non-emergency response business increased by 8% year-over-year in Q2 2024, while emergency response business saw a 92% decline [6][9] - Excluding emergency response revenue, sales increased by 10% in the first half of 2024 [10] Market Data and Key Metrics Changes - The company achieved the highest number of active customer sites ever, with a 15% increase over the previous year, totaling 1,384 active accounts by the end of Q2 2024 [6][19] Company Strategy and Development Direction - The company is focusing on long-term growth initiatives, including the expansion of digital tools like the filter tracking app to enhance customer engagement [7][8] - Nephros is strategically positioning itself to capitalize on growth opportunities in sectors beyond hospitals, such as dental practices and endoscopy processing [8] Management's Comments on Operating Environment and Future Outlook - Management noted a decline in emergency response business due to reduced stringency in waterborne risk response, but anticipates potential recovery with upcoming regulatory changes [7][15] - The company remains committed to innovation and customer engagement while focusing on profitability and return on investment [12] Other Important Information - The balance sheet remains strong with a cash balance of approximately $3.1 million as of June 30, 2024, despite a decrease from $4.3 million at the end of 2023 [11] Q&A Session Summary Question: Can you elaborate on the reduced stringency for waterborne risk response? - Management identified that the Ohio Department of Health reduced testing due to system overload, which may lead to a return to higher emergency responses with upcoming regulatory changes [14][15] Question: Update on the filter tracker rollout? - The rollout faced initial issues but recent updates have improved functionality. Management believes the tracker will help increase reorder rates for filters [17][18] Question: Total number of active accounts at the end of Q2? - The total number of active accounts as of the end of Q2 2024 was 1,384 [19]

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ...

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ...

Nephros, Inc. (NASDAQ:NEPH) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Kirin Smith - Investor Relations Robert Banks - Chief Executive Officer Judy Krandel - Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim Group Nick Farwell - Arbor Group Ralph Weil - R. Weil Investment Management Operator Good afternoon, and welcome to the Nephros, Inc. First Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or other ...

Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Financial Results for Quarter Ended March 31, 2024 First-Quarter Net Revenue of $3.5 Million; Technology advancements and microplastics capabilities on the horizon SOUTH ORANGE, NJ, May 09, 2024 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32288 NEPHROS, INC. (Exact name of registrant specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 13-39 ...

Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call:201 343 5202 nephros.com Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 7, 2024 – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended Decemb ...